Papapetropoulos Spyridon 4
4 · Vigil Neuroscience, Inc. · Filed Mar 3, 2022
Insider Transaction Report
Form 4
Papapetropoulos Spyros
Chief Medical Officer
Transactions
- Award
Stock Option Grant (Right to Buy)
2022-03-01+75,500→ 75,500 totalExercise: $16.13Exp: 2032-03-01→ Common Stock (75,500 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest and become exercisable in forty-eight (48) equal monthly installments, with the first installment vesting on April 1, 2022.